NCT04914637

Brief Summary

Chronic neck pain is among the most frequently seen chronic painful conditions. As an important cause of disability, chronic neck pain is a musculoskeletal disorder that negatively affects quality of life. Cervical disc herniation is one of the leading causes of chronic neck pain and conservative methods such as exercise and pain medications are used first in the treatment. In patients unresponsive to conservative treatment, epidural steroid injection is successfully and frequently used treatment option. Epidural steroid injection in the cervical region can be applied with two approaches: interlaminar or transforaminal. Myofascial trigger point characterized by intramuscular taut band and hypersensitive spots is a condition in which central and peripheral sensitization play a role in the pathophysiology. There are underlying myofascial trigger points in many etiologies that cause chronic neck pain. Trigger points can increase the severity of pain and in some cases they can be the main factor in the etiology of pain. Therefore, the presence of myofascial trigger points should be investigated, even if another cause is detected in chronic neck pain. Dry needling is an easily applicable and effective treatment option in myofascial trigger point. Although it is well known that myofascial trigger points frequently accompany cervical disc herniation, their effect on treatment outcomes has not been investigated. In this study, we aimed to investigate the effect of dry needling for trigger points on the treatment results of interlaminar epidural steroid injection in patients diagnosed with cervical disc herniation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

June 4, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

5 months

First QC Date

May 30, 2021

Last Update Submit

November 28, 2023

Conditions

Keywords

myofascial trigger point paindisc, herniatedepidural injections

Outcome Measures

Primary Outcomes (2)

  • Change of pain severity from baseline to each checkpoints

    Pain severity will be assessed with Numeric Rating Scale (NRS). The patient scores his/her pain between 0-10. Higher score indicates more severe pain

    from pre-interventional time to post-interventional 1st hour, 3rd week, 3rd month

  • Change of the number of active trigger points from baseline to each checkpoints

    The number of active trigger points will be determined by clinical examination. The trigger point will be defined as "active" if it causes spontaneous pain or pain occured during the examination is familiar to the patient.

    from pre-interventional time to post-interventional 3rd week, 3rd month

Secondary Outcomes (7)

  • Change of depression severity from baseline to each checkpoints

    from pre-interventional time to post-interventional 3rd week, 3rd month

  • Change of the number of the patients with neuropathic pain from baseline to each checkpoints

    from pre-interventional time to post-interventional 3rd week, 3rd month

  • Change of the number of the patients with central sensitization from baseline to each checkpoints

    from pre-interventional time to post-interventional 3rd week, 3rd month

  • Change of the measurement of quality of life from baseline to each checkpoints

    from pre-interventional time to post-interventional 3rd week, 3rd month

  • Change of the measurement of disability related with chronic neck pain from baseline to each checkpoints

    from pre-interventional time to post-interventional 3rd week, 3rd month

  • +2 more secondary outcomes

Study Arms (3)

interlaminar epidural steroid injection plus dry needling

ACTIVE COMPARATOR

Fluoroscopy-guided cervical interlaminar epidural steroid injection will be administered to patients with chronic neck pain due to cervical disc herniation. Also, dry needling will be applied to the active trigger points for the patients in this group. Interlaminar epidural steroid injection will be applied at week 0, while dry needling will be applied in 3 sessions per week (week 0, week 1, week 2). The first session of the dry needling will be in the same day with interlaminar epidural steroid injection.

Procedure: Cervical interlaminar epidural steroid injectionProcedure: Dry needling

interlaminar epidural steroid injection plus sham dry needling

SHAM COMPARATOR

Fluoroscopy-guided cervical interlaminar epidural steroid injection will be administered same as the arm titled "interlaminar epidural steroid injection plus dry needling". The only difference in the interventions in this arm is that dry needling is applied without penetrating the skin. The blunt tip of the needle will be used in sham intervention. Interlaminar epidural steroid injection will be applied at week 0, while sham dry needling will be applied in 3 sessions per week (week 0, week 1, week 2)

Procedure: Cervical interlaminar epidural steroid injectionProcedure: Sham dry needling

interlaminar epidural steroid injection only

OTHER

Only interlaminar epidural steroid injection will be administered to patients in this arm with the same method as in the other arms (one session, week 0). No dry needling or sham dry needling will be used.

Procedure: Cervical interlaminar epidural steroid injection

Interventions

Fluoroscopy-guided cervical interlaminar epidural steroid injection will be administered to patients with chronic neck pain due to cervical disc herniation. The injection area is cleaned 3 times with an antiseptic solution and covered with a sterile cloth. Local anesthesia with 2 cc 3% prilocaine will be applied to the skin and subcutaneous tissues in the area of interest. Under fluoroscopy guidance, the needle is advanced into the C7-T1 intervertebral disc level. With the help of the loss of resistance technique, it is understood that the needle is in the epidural space, and second control is provided by administering contrast material. After the confirmation of needle place is done, a mixture of 12 mg dexamethasone, 1 cc 2% lidocaine, 1 cc saline is injected. The patient is taken to the rest room after the procedure and followed up for any complications.

interlaminar epidural steroid injection onlyinterlaminar epidural steroid injection plus dry needlinginterlaminar epidural steroid injection plus sham dry needling
Dry needlingPROCEDURE

Dry needling will be applied to the active trigger points for the patients in this group. After cleaning the area of interest with an antiseptic solution, dry needling will be applied with the fast-in/fast-out technique for the active trigger point. During needle maneuvers, local contractions (local twitch response-LTR) are obtained and rapid needle movements are continued until the contractions end. Afterwards, the needle is removed and compression is applied to ensure hemostasis in the relevant area.

interlaminar epidural steroid injection plus dry needling

Although the method of intervention is like dry needling, the only difference is that the blunt end of the needle is used and it does not penetrate the skin.

interlaminar epidural steroid injection plus sham dry needling

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18-65
  • Chronic neck pain due to cervical disc herniation for at least 3 months and being unresponsive to conservative treatment
  • Presence of at least one active myofascial trigger point on physical examination of cervical paraspinal muscles, scapulothoracic muscles and extremity muscles.

You may not qualify if:

  • Previous surgical/interventional procedure for the cervical region
  • Previous application of dry needling/acupuncture to any part of the body
  • Presence of other musculoskeletal disorders (such as lateral epicondylitis, tendinitis, entrapment neuropathy) that may cause diagnostic confusion in terms of pain pattern and localization
  • Signs of trauma, fracture, malignancy, or active infection
  • Rheumatological (RA, AS, etc.), endocrinological (such as osteoporosis, Paget's disease) or another systemic disease that may change the anatomical or physiological structure of the relevant regions
  • Presence of coagulopathy
  • History of whiplash injury, cervical spinal stenosis, cervical spondylosis
  • Have a diagnosis of fibromyalgia
  • Being pregnant and breastfeeding
  • Presence of mental deterioration or psychiatric/neurological disease that can affect flow of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Pendik Education and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Yolcu G, Toprak CS, Sencan S, Gunduz OH. Dry Needling Plus Cervical Interlaminar Epidural Steroid Injections: Do We Have More Favorable Results in Cervical Disc Herniation? A Randomized Sham-Controlled Clinical Study. Am J Phys Med Rehabil. 2024 Dec 1;103(12):1081-1087. doi: 10.1097/PHM.0000000000002509.

MeSH Terms

Conditions

Facial PainNeck PainChronic PainMyofascial Pain SyndromesIntervertebral Disc Displacement

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesSpinal DiseasesBone DiseasesHerniaPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Osman Hakan Gunduz, MD

    Marmara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2021

First Posted

June 4, 2021

Study Start

June 4, 2021

Primary Completion

October 31, 2021

Study Completion

November 1, 2021

Last Updated

November 29, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations